Avalon Investment & Advisory’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-5,465
Closed -$274K – 336
2021
Q4
$274K Sell
5,465
-2,486
-31% -$123K 0.01% 281
2021
Q3
$383K Sell
7,951
-1,077
-12% -$54.8K 0.01% 296
2021
Q2
$475K Sell
9,028
-1,405
-13% -$73.3K 0.01% 282
2021
Q1
$516K Sell
10,433
-2,198
-17% -$106K 0.01% 280
2020
Q4
$614K Buy
12,631
+968
+8% +$47.7K 0.01% 280
2020
Q3
$585K Buy
11,663
+893
+8% +$46K 0.01% 255
2020
Q2
$550K Buy
10,770
+372
+4% +$18.1K 0.01% 239
2020
Q1
$455K Buy
+10,398
New +$498K 0.01% 261
2016
Q2
– Sell
-21,718
Closed -$872K – 292
2016
Q1
$872K Buy
21,718
+4,683
+27% +$188K 0.04% 160
2015
Q4
$727K Sell
17,035
-2,387
-12% -$110K 0.03% 179
2015
Q3
$922K Buy
19,422
+6,800
+54% +$346K 0.04% 147
2015
Q2
$625K Buy
12,622
+4,372
+53% +$222K 0.03% 181
2015
Q1
$408K Buy
8,250
+3,614
+78% +$173K 0.02% 195
2014
Q4
$211K Buy
+4,636
New +$225K 0.01% 217

Other funds holding SNY

Avalon Investment & Advisory's SNY Position: Q1 2022 in Review

Avalon Investment & Advisory sold out of Sanofi (SNY) in Q1 2022, closing a stake of 5,465 shares — an estimated $274K sold.

Avalon Investment & Advisory first reported a position in SNY in Q4 2014 and held it in 14 quarters. The position peaked at $922K in Q3 2015. 623 funds tracked by Wall St. Rank hold SNY as of Q1 2022.

  • Avalon Investment & Advisory reported no remaining Sanofi position as of Q1 2022 after selling out during the quarter.
  • Avalon Investment & Advisory sold 5,465 Sanofi shares in Q1 2022, an estimated $274K.
  • Avalon Investment & Advisory first reported a position in Sanofi in Q4 2014 and held it in 14 quarters.
  • Avalon Investment & Advisory's Sanofi position peaked at $922K in Q3 2015.
  • 623 funds tracked by Wall St. Rank held Sanofi as of Q1 2022.

Based on Avalon Investment & Advisory's 13F filing for Q1 2022, filed 17 May 2022.